Annual CFO
-$117.48 M
-$14.74 M-14.34%
December 31, 2022
Summary
- As of February 10, 2025, KDNY annual cash flow from operations is -$117.48 million, with the most recent change of -$14.74 million (-14.34%) on December 31, 2022.
- During the last 3 years, KDNY annual CFO has fallen by -$103.89 million (-764.59%).
Performance
KDNY Cash From Operations Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Quarterly CFO
-$61.20 M
-$10.53 M-20.78%
June 30, 2023
Summary
- As of February 10, 2025, KDNY quarterly cash flow from operations is -$61.20 million, with the most recent change of -$10.53 million (-20.78%) on June 30, 2023.
- Over the past year, KDNY quarterly CFO has dropped by -$30.58 million (-99.87%).
Performance
KDNY Quarterly CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
TTM CFO
-$174.00 M
-$30.58 M-21.32%
June 30, 2023
Summary
- As of February 10, 2025, KDNY TTM cash flow from operations is -$174.00 million, with the most recent change of -$30.58 million (-21.32%) on June 30, 2023.
- Over the past year, KDNY TTM CFO has dropped by -$71.43 million (-69.64%).
Performance
KDNY TTM CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Cash From Operations Formula
CFO = Net Income + Non Cash Expenses + Changes In Working Capital
KDNY Cash From Operations Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -14.3% | -99.9% | -69.6% |
| 3 y3 years | -764.6% | -1545.9% | -2314.7% |
| 5 y5 years | -764.6% | - | - |
KDNY Cash From Operations Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | +14.3% | at low | +172.0% | at low | +75.1% | at low |
| 5 y | 5-year | +764.6% | at low | +1654.4% | at low | +4888.6% | at low |
| alltime | all time | +764.6% | at low | +1654.4% | at low | +4888.6% | at low |
Chinook Therapeutics Cash From Operations History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2023 | - | -$61.20 M(+20.8%) | -$174.00 M(+21.3%) |
| Mar 2023 | - | -$50.67 M(+37.6%) | -$143.43 M(+22.1%) |
| Dec 2022 | -$117.48 M(+14.3%) | -$36.83 M(+45.5%) | -$117.48 M(+13.9%) |
| Sep 2022 | - | -$25.31 M(-17.3%) | -$103.15 M(+0.6%) |
| Jun 2022 | - | -$30.62 M(+23.8%) | -$102.57 M(+3.2%) |
| Mar 2022 | - | -$24.72 M(+9.9%) | -$99.39 M(-3.3%) |
| Dec 2021 | -$102.74 M | -$22.50 M(-9.0%) | -$102.74 M(-15.5%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2021 | - | -$24.73 M(-9.8%) | -$121.54 M(+16.7%) |
| Jun 2021 | - | -$27.43 M(-2.3%) | -$104.16 M(+29.5%) |
| Mar 2021 | - | -$28.08 M(-32.0%) | -$80.44 M(+44.0%) |
| Dec 2020 | -$55.85 M(+311.0%) | -$41.30 M(+462.3%) | -$55.85 M(+283.8%) |
| Sep 2020 | - | -$7.34 M(+97.5%) | -$14.55 M(+101.9%) |
| Jun 2020 | - | -$3.72 M(+6.6%) | -$7.21 M(+106.6%) |
| Mar 2020 | - | -$3.49 M | -$3.49 M |
| Dec 2019 | -$13.59 M | - | - |
FAQ
- What is Chinook Therapeutics annual cash flow from operations?
- What is the all time high annual CFO for Chinook Therapeutics?
- What is Chinook Therapeutics annual CFO year-on-year change?
- What is Chinook Therapeutics quarterly cash flow from operations?
- What is the all time high quarterly CFO for Chinook Therapeutics?
- What is Chinook Therapeutics quarterly CFO year-on-year change?
- What is Chinook Therapeutics TTM cash flow from operations?
- What is the all time high TTM CFO for Chinook Therapeutics?
- What is Chinook Therapeutics TTM CFO year-on-year change?
What is Chinook Therapeutics annual cash flow from operations?
The current annual CFO of KDNY is -$117.48 M
What is the all time high annual CFO for Chinook Therapeutics?
Chinook Therapeutics all-time high annual cash flow from operations is -$13.59 M
What is Chinook Therapeutics annual CFO year-on-year change?
Over the past year, KDNY annual cash flow from operations has changed by -$14.74 M (-14.34%)
What is Chinook Therapeutics quarterly cash flow from operations?
The current quarterly CFO of KDNY is -$61.20 M
What is the all time high quarterly CFO for Chinook Therapeutics?
Chinook Therapeutics all-time high quarterly cash flow from operations is -$3.49 M
What is Chinook Therapeutics quarterly CFO year-on-year change?
Over the past year, KDNY quarterly cash flow from operations has changed by -$30.58 M (-99.87%)
What is Chinook Therapeutics TTM cash flow from operations?
The current TTM CFO of KDNY is -$174.00 M
What is the all time high TTM CFO for Chinook Therapeutics?
Chinook Therapeutics all-time high TTM cash flow from operations is -$3.49 M
What is Chinook Therapeutics TTM CFO year-on-year change?
Over the past year, KDNY TTM cash flow from operations has changed by -$71.43 M (-69.64%)